Clinical features and outcomes of invasive pneumococcal disease in a pediatric intensive care unit

被引:10
作者
Hsiao, Hsiang-Ju [1 ,2 ]
Wu, Chang-Teng [2 ,3 ]
Huang, Jing-Long [2 ,4 ]
Chiu, Cheng-Hsun [2 ,5 ]
Huang, Yhu-Chering [2 ,6 ]
Lin, Jainn-Jim [2 ,7 ]
Huang, I-Anne [1 ,2 ]
Chan, Oi-Wa [2 ,7 ]
Chou, I-Jun [2 ,3 ]
Hsia, Shao-Hsuan [2 ,7 ]
机构
[1] Chang Gung Mem Hosp, Dept Pediat, Keelung, Taiwan
[2] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
[3] Chang Gung Mem Hosp, Dept Pediat, Div Gen Pediat, Linkou, Taiwan
[4] Chang Gung Mem Hosp, Dept Pediat, Div Asthma Allergy & Rheumatol, Linkou, Taiwan
[5] Chang Gung Mem Hosp, Mol Infect Dis Res Ctr, Div Pediat Infect, Linkou, Taiwan
[6] Chang Gung Mem Hosp, Dept Pediat, Div Pediat Infect Dis, Linkou, Taiwan
[7] Chang Gung Mem Hosp, Dept Pediat, Div Pediat Crit Care Med, Linkou, Taiwan
来源
BMC PEDIATRICS | 2015年 / 15卷
关键词
Hemolytic uremic syndrome (HUS); herd immunity; invasive pneumococcal disease; mortality; pediatric intensive care unit; pneumococcal conjugate vaccine; serotype; 19; F; Streptococcus pneumoniae; HEMOLYTIC-UREMIC SYNDROME; CONJUGATE VACCINE; BACTERIAL-MENINGITIS; STREPTOCOCCUS-PNEUMONIAE; SEROTYPE; 19A; TAIWAN; CHILDREN; SURVEILLANCE; EMERGENCE; ADULTS;
D O I
10.1186/s12887-015-0387-7
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Invasive pneumococcal disease (IPD) results in high morbidity and mortality globally each year, although it is a vaccine-preventable disease. This study aimed to characterize the clinical features of IPD in a pediatric intensive care unit (PICU) in Taiwan. The seven-valent pneumococcal conjugate vaccine (PCV7) was introduced in the private sector in October 2005. The estimated coverage rate of PCV7 vaccination in 2010 was 45.5 % among children < 5 years of age. Methods: We conducted a retrospective study at a single center in northern Taiwan for invasive pneumococcal disease in a PICU from 2009 to 2013. Demographic characteristics, clinical courses, serotype, antibiotic susceptibility, and outcomes were analyzed. Results: Over the 5-year study period, 2167 patients were admitted to the PICU; 48 (2.2 %) had IPD. There were 29 female and 19 male patients. Their mean age was 3.7 years (range 0.7-12.5 years, with the peak age at 2-5 years; n = 30, 63 %). Pneumonia was the most frequent type (n = 38, 79 %), followed by meningitis (n = 10, 21 %). In total, three patients died, all within 72 h after admission; the final diagnoses were all meningitis. Thirty-four children with pneumonia received chest tube insertion for pleural effusion drainage. Of them, 22 (65 %) finally still underwent video-assisted thoracoscopic surgery. Eight (17 %) children had hemolytic uremic syndrome, and seven of them underwent hemodialysis. In total, 37 serotypes were detected; 95 % were covered by PCV13. Serotype 19A was most common (54 %) overall; however, in those with meningitis, serotype 19 F was most common. Conclusions: Meningitis is the most severe type of invasive pneumococcal disease in our pediatric intensive care unit. It may progress rapidly even when subjects are given antibiotics promptly. The most common serotype in meningitis is 19 F, which is vaccine preventable. Thus, universal mass pneumococcal vaccination is still needed.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Invasive Pneumococcal Disease in Two Non-Vaccinated Pediatric Cases: Pleural Empyema and Bacteremia
    Kanik Yuksek, Saliha
    Gulhan, Belgin
    Tezer, Hasan
    Ozkaya Parlakay, Aslinur
    Uzun Kenan, Bahriye
    Sayed Oskovi, Hulya
    Nar Otgun, Selin
    MIKROBIYOLOJI BULTENI, 2015, 49 (03): : 446 - 453
  • [32] Rapid diagnosis of invasive pneumococcal disease in pediatric population
    Jose Picazo, Juan
    Ruiz Contreras, Jesus
    Rios, Esther
    Culebras, Esther
    Rodriguez-Avial, Iciar
    Mendez, Cristina
    Betriu, Carmen
    JOURNAL OF MICROBIOLOGICAL METHODS, 2013, 93 (02) : 116 - 120
  • [33] Impact of Introduction of Conjugate Vaccines in the Vaccination Schedule on the Incidence of Pediatric Invasive Pneumococcal Disease Requiring Hospitalization in Madrid 2007 to 2011
    Picazo, Juan
    Ruiz-Contreras, Jesus
    Casado-Flores, Juan
    Giangaspro, Elisa
    Garcia-de-Miguel, Maria-Jesus
    Hernandez-Sampelayo, Teresa
    Otheo, Enrique
    Mendez, Cristina
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (06) : 656 - 661
  • [34] Clinical Characteristics, Antimicrobial Resistance, and Outcomes of Patients with Invasive Pneumococcal Disease in Ningxia Hui Autonomous Region, China, 2013-2021
    Tao, Jia
    Wang, Wen
    Li, Gang
    Wang, Linlin
    Wang, Liang
    Zhao, Zhijun
    Jia, Wei
    Wang, Liru
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2022, 2022
  • [35] Pediatric Invasive Pneumococcal Disease in Taiwan Following a National Catch-up Program With the 13-Valent Pneumococcal Conjugate Vaccine
    Wei, Sung-Hsi
    Chiang, Chuen-Sheue
    Chiu, Cheng-Hsun
    Chou, Pesus
    Lin, Tzou-Yien
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2015, 34 (03) : E71 - E77
  • [36] Pediatric Cancer Outcomes in an Intensive Care Unit in Pakistan
    Sial, Gull Zareen Khan
    Khan, Saadiya Javed
    JOURNAL OF GLOBAL ONCOLOGY, 2019, 5 : 1 - 5
  • [37] Low opsonic activity to the infecting serotype in pediatric patients with invasive pneumococcal disease
    Oishi, Tomohiro
    Ishiwada, Naruhiko
    Matsubara, Kousaku
    Nishi, Junichiro
    Chang, Bin
    Tamura, Kazuyo
    Akeda, Yukihiro
    Ihara, Toshiaki
    Nahm, Moon H.
    Oishi, Kazunori
    VACCINE, 2013, 31 (05) : 845 - 849
  • [38] Invasive Candidiasis in Pediatric Intensive Care Unit: More Challenges
    Pana, Zoi Dorothea
    Kotzadamis, Dimitrios
    Roilides, Emmanuel
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2018, 37 (12) : 1309 - 1311
  • [39] One year period of invasive pneumococcal disease in children from a tertiary care hospital in Turkey in the post-vaccine era
    Ustundag, Gulnihan
    Karadag-Oncel, Eda
    Sen-Tas, Sebahat
    Kara-Aksay, Ahu
    Yilmaz-Ciftdogan, Dilek
    Yilmaz, Nisel
    Ceyhan, Mehmet
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (05) : 1470 - 1473
  • [40] Dynamic changes in clinical characteristics and serotype distribution of invasive pneumococcal disease among adults in Japan after introduction of the pediatric 13-valent pneumococcal conjugate vaccine in 2013-2019
    Tamura, Kosuke
    Chang, Bin
    Shimbashi, Reiko
    Watanabe, Hiroshi
    Tanabe, Yoshinari
    Kuronuma, Koji
    Oshima, Kengo
    Maruyama, Takaya
    Fujita, Jiro
    Abe, Shuichi
    Kasahara, Kei
    Nishi, Junichiro
    Kubota, Tetsuya
    Kinjo, Yuki
    Fujikura, Hiroyuki
    Fukusumi, Munehisa
    Shimada, Tomoe
    Sunagawa, Tomimasa
    Suzuki, Motoi
    Yamamoto, Yoshihiro
    Oishi, Kazunori
    VACCINE, 2022, 40 (24) : 3338 - 3344